References
- Zelickson A. The Langerhans cell. J Invest Dermatol 1965; 44: 201–213
- Braathen L, Thorsby E. Studies on human epidermal Langerhans cells. I. Allo-activating and antigen-presenting capacity. Scand J Immunol 1980; 11: 401–408
- Stanfield J P, Bracken P M, Waddell K M, Gall D. Diphtheria-tetanus-pertussis immunization by intradermal jet injection. Br Med J 1972; 9: 197–199
- Philippines Cholera Committee. A controlled field trial on the effectiveness of the intradermal and subcutaneous administration of cholera vaccine in the Philippines. Bull WHO 1973; 49: 389–394
- Iwarson S, Larsson P. Intradermal versus subcutaneous immunization with typhoid vaccine. J Hyg 1980; 84: 11–16
- Research Committee of the British Thoracic and Tuberculosis Association. A comparison of intradermal BCG vaccination by jet injection and by syringe and needle. Tubercle 1971; 52: 155–165
- Payler D K, Skirrow M B. Intradermal influenza vaccination. Br Med J 1974; 2: 727
- Warrell M J, Nicholson K G, Chanthavanich P, Sinhaseni A, Xuref C, Suntharasamai P, Warrell D A, Viravan C, Phanfung R, Vincent-Falquet J C. Multisite intradermal and multisite subcutaneous rabies vaccination: improved economical regimens. Lancet 1984; 1: 874–876
- Wahi M, Hermodsson S, Iwarson S. Long-term follow up of the immune response to hepatitis B vaccine in patients with Down's syndrome. Serodiagnosis Immunother 1987; 1: 45–50
- Hollinger F B, Adam E, Heiberg D, Melnick J L. Response to hepatitis B vaccine in a young adult population. Viral hepatitis, W Szmuness, H J Alter, J E Maynards. Franklin Institute Press, Philadelphia 1982; 451–466
- Zoulek G, Lorbeer B, Jilg W, Deinhardt F. Antibody responses and skin reactivity after intradermal hepatitis B virus vaccine. Lancet 1984; 1: 568
- Redfield R R, Innis B L, McNair Scott R, Cannon H G, Bancroft W H. Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. JAMA 1985; 254: 3203–3206
- Irving W L, Alder M, Kurtz J B, Juel-Jensen B. Intradermal vaccination against hepatitis B. Lancet 1986; 2: 1340
- Miller K D, Gibbs R D, Mulligan M M, Nutman T B, Francis D P. Intradermal hepatitis B virus vaccine: Immunogenicity and side-effects in adults. Lancet 1983; 2: 1454–1456
- Moyes C D, Milne A, Dimitrakakis M, Goldwater P N, Pearce N. Very-low-dose hepatitis B vaccine in newborn infants: An economic option for control in endemic areas. Lancet 1987; 1: 29–31
- Denis F, Mounier M, Hessel L, Michel J P, Gualde N, Dubois F, Barin F, Goudeau A. Hepatitis-B vaccination in the elderly. J Infect Dis 1984; 149: 1019
- Stevens C E, Alter H J, Taylor P E, Zang E A, Harley E J, Szmuness W. and the Dialysis Vaccine Trial Study group. Hepatitis B vaccine in patients receiving hemodialysis: Immunogenicity and efficacy. N Engl J Med 1984; 311: 496–501